These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34384037)

  • 1. Behavioral, Biochemical and Histopathological effects of Standardised Pomegranate extract with Vinpocetine, Propolis or Cocoa in a rat model of Parkinson's disease.
    Ali AA; Kamal MM; Khalil MG; Ali SA; Elariny HA; Bekhit A; Wahid A
    Exp Aging Res; 2022; 48(2):191-210. PubMed ID: 34384037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the neuroprotective activities of vinpocetine, punicalagin, niacin and vitamin E against behavioural and motor disabilities of manganese-induced Parkinson's disease in Sprague Dawley rats.
    Abu-Elfotuh K; Hamdan AME; Abbas AN; Alahmre ATS; Elewa MAF; Masoud RAE; Ali AA; Othman M; Kamal MM; Hassan FAM; Khalil MG; El-Sisi AM; Abdel Hady MMM; Abd-Elhaleim El Azazy MK; Awny MM; Wahid A
    Biomed Pharmacother; 2022 Sep; 153():113330. PubMed ID: 35780621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats.
    Zaitone SA; Abo-Elmatty DM; Elshazly SM
    Indian J Pharmacol; 2012; 44(6):774-9. PubMed ID: 23248410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
    Abdin AA; Hamouda HE
    Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icariin attenuates dopaminergic neural loss in haloperidol-induced Parkinsonism in rats via GSK-3β and tyrosine hydroxylase regulation mechanism.
    Sabry HA; Zahra MM
    J Chem Neuroanat; 2024 Mar; 136():102385. PubMed ID: 38160784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Alzheimer Activity of Combinations of Cocoa with Vinpocetine or Other Nutraceuticals in Rat Model: Modulation of Wnt3/β-Catenin/GSK-3β/Nrf2/HO-1 and PERK/CHOP/Bcl-2 Pathways.
    Abu-Elfotuh K; Tolba AMA; Hussein FH; Hamdan AME; Rabeh MA; Alshahri SA; Ali AA; Mosaad SM; Mahmoud NA; Elsaeed MY; Abdelglil RM; El-Awady RR; Galal ERM; Kamal MM; Elsisi AMM; Darwish A; Gowifel AMH; Mahran YF
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of vinpocetine against neurotoxicity of manganese in adult male rats.
    Nadeem RI; Ahmed HI; El-Sayeh BM
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jul; 391(7):729-742. PubMed ID: 29671021
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Chang HC; Liu KF; Teng CJ; Lai SC; Yang SE; Ching H; Wu CR
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.
    Johnston TH; Versi E; Howson PA; Ravenscroft P; Fox SH; Hill MP; Reidenberg BE; Corey R; Brotchie JM
    Neuropharmacology; 2018 Mar; 131():116-127. PubMed ID: 29197517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorating effect of
    Abdel-Kawy MA; Aboulhoda BE; Michel CG; Sedeek MS; Kirollos FN; Masoud MA
    Nutr Neurosci; 2024 Jul; 27(7):770-782. PubMed ID: 37658797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin pathway.
    Ahmed HI; Abdel-Sattar SA; Zaky HS
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1327-1338. PubMed ID: 30083945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation.
    Ishola IO; Akinyede AA; Adeluwa TP; Micah C
    Metab Brain Dis; 2018 Oct; 33(5):1493-1500. PubMed ID: 29855979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic action of propolis with levodopa in the management of Parkinsonism in Drosophila melanogaster.
    Ayikobua ET; Kasolo J; Kasozi KI; Eze ED; Safiriyu A; Ninsiima HI; Kiyimba K; Namulema J; Jjesero E; Ssempijja F; Semuyaba I; Mwandah DC; Kimanje KR; Kalange M; Okpanachi AO; Nansunga M
    J Complement Integr Med; 2020 Sep; 17(3):. PubMed ID: 32386191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Yang X; Zhao H; Shi H; Wang X; Zhang S; Zhang Z; Zu J; Zhang W; Shen X; Cui G; Hua F
    Exp Neurol; 2015 Sep; 271():168-74. PubMed ID: 26001615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats.
    Sharma S; Deshmukh R
    Neuroscience; 2015 Feb; 286():393-403. PubMed ID: 25514048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-β1, NF-κB and glucagon-like peptide 1.
    Kabel AM; Omar MS; Alhadhrami A; Alharthi SS; Alrobaian MM
    Physiol Behav; 2018 May; 188():108-118. PubMed ID: 29410018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT
    Pinna A; Costa G; Serra M; Contu L; Morelli M
    Neuropharmacology; 2021 Sep; 196():108693. PubMed ID: 34229013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective potential of Beta vulgaris L. in Parkinson's disease.
    Nade VS; Kawale LA; Zambre SS; Kapure AB
    Indian J Pharmacol; 2015; 47(4):403-8. PubMed ID: 26288473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice.
    Zaitone SA; Hammad LN; Farag NE
    Pharmacol Rep; 2013; 65(5):1213-26. PubMed ID: 24399717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.